Biomarkers in early-stage colorectal cancer: ready for prime time?
BACKGROUND/AIMS: During the last two decades, hundreds of reports have detailed putative prognostic and predictive biomarkers for colorectal cancer (CRC). However, the majority of these studies have been small and retrospective, reporting results that are highly likely to represent false positives....
Hlavní autoři: | Church, D, Midgley, R, Kerr, D |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2012
|
Podobné jednotky
-
Adjuvant chemotherapy for stage II colorectal cancer: the time is right!
Autor: Midgley, R, a další
Vydáno: (2005) -
The emergence of 'omics for the management of colorectal cancer.
Autor: Midgley, R, a další
Vydáno: (2011) -
Adjuvant chemotherapy for stage II colorectal cancer: who should receive therapy and with what?
Autor: Midgley, R, a další
Vydáno: (2005) -
Circulating tumor DNA in early-stage colon cancer: ready for prime time or needing refinement?
Autor: Joao Paulo Solar Vasconcelos, a další
Vydáno: (2022-12-01) -
Immunotherapy for colorectal cancer.
Autor: Midgley, R, a další
Vydáno: (2003)